Both in Pharmaceuticals
Kiora Pharmaceuticals vs Ensysce Biosciences
Over the past year KPRX returned −30.0% and ENSC returned −82.4%; their daily moves had a correlation of 0.03.
KPRX −30.0% ENSC −82.4%Growth of $1, one year, split-adjusted
| Metric | KPRX | ENSC |
|---|---|---|
| Price | $1.73 | $0.3777 |
| Market cap | $7.7M | $7.3M |
| Today | +6.13% | −1.15% |
| 1 month | −31.6% | −9.9% |
| 6 months | −31.1% | −5.6% |
| Year to date | −12.2% | −58.9% |
| 1 year | −25.1% | −82.7% |
| Revenue growth (YoY) | — | −15.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −220.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.6× |
| Net cash | $16.8M | $479.9K |
| Dividend yield | — | — |
| Volatility (60d) | 73.5% | 89.5% |
| Short % of float | 0.1% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).